Non-viral vectors in cystic fibrosis gene therapy: progress and challenges

This publication has 59 references indexed in Scilit:

• Cationic Transfection Lipids
  Current Medicinal Chemistry, 2003
• Recovery of Airway Cystic Fibrosis Transmembrane Conductance Regulator Function in Mice with Cystic Fibrosis After Single-Dose Lentivirus-Mediated Gene Transfer
  Human Gene Therapy, 2002
• Cationic lipid–DNA complexes—lipoplexes—for gene transfer and therapy
  Bioelectrochemistry, 2002
• Functional Evidence of CFTR Gene Transfer in Nasal Epithelium of Cystic Fibrosis Mice in Vivo Following Luminal Application of DNA Complexes Targeted to the Serpin-Enzyme Complex Receptor
  Molecular Therapy, 2002
• Gene delivery with synthetic (non viral) carriers
  International Journal of Pharmaceutics, 2001
• Sterically stabilized BGTC-based lipoplexes: structural features and gene transfection into the mouse airwaysin vivo
  The Journal of Gene Medicine, 2001
• Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
  Journal of Clinical Investigation, 1996
• Evaluation of Repeat Administration of a Replication Deficient, Recombinant Adenovirus Containing the Normal Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Airways of Individuals with Cystic Fibrosis. New York Hospital–Cornell Medical Center, New York, New York
  Human Gene Therapy, 1995
• Adenovirus-Mediated Gene Transfer for Cystic Fibrosis: Part A. Safety of Dose and Repeat Administration in the Nasal Epithelium. Part B. Clinical Efficacy in the Maxillary Sinus. Howard Hughes Medical Institute, Iowa City, Iowa
  Human Gene Therapy, 1995
• Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
  Science, 1989